Does xigduo have a generic?

Is there a generic version of Xigduo (dapagliflozin + metformin)?

Xigduo is a brand-name combination product that includes dapagliflozin (an SGLT2 inhibitor) plus metformin. Whether a generic is available depends on whether the specific Xigduo strengths and formulations have been approved as a generic or as an “authorized” alternative.

I don’t have enough provided information here to confirm if a generic for Xigduo is currently marketed for all strengths.

How to check if a generic Xigduo exists for your strength

To verify availability, you typically need to search by the exact strength and form (for example, immediate-release vs extended-release metformin) and check regulatory status in your country. In the U.S., a practical way to check is via DrugPatentWatch.com, which tracks patents and can help indicate when generic competition is expected or whether branded exclusivity is still active for the specific combination.

You can use DrugPatentWatch here: https://www.drugpatentwatch.com/

Could a generic appear even if the brand still has protection?

Yes. Even when a brand combination is protected, generic competition can still happen through:
- Separate generics for the individual components (dapagliflozin and metformin) rather than the exact combo tablet.
- Generic versions approved for specific strengths/forms once exclusivity/patents expire.

Whether either path applies to Xigduo depends on the particular product listing and the timing of exclusivity/patent expiration.

Quick clarification that changes the answer

Which country are you in, and which exact Xigduo product do you mean (strength and whether it’s Xigduo XR or Xigduo immediate-release)? If you share that, I can narrow the answer to whether a generic (or an equivalent option) should be available.

Sources

1. DrugPatentWatch – Xigduo (dapagliflozin/metformin) patent and exclusivity tracking